TARS vs REGN: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
—
REGN
Regeneron Pharmaceuticals Inc
$677.53
Key Metrics Comparison
| Metric | TARS | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.66B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TARS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or REGN a better investment?
Comparing TARS and REGN: Tarsus Pharmaceuticals Inc has a market cap of $2.66B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and REGN?
TARS (Tarsus Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or REGN?
Both TARS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TARS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TARS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $2.66B for TARS.
Should I buy TARS or REGN in 2026?
Both TARS and REGN have investment merit. TARS trades at $N/A while REGN trades at $677.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and REGN stock?
Key differences: Market Cap ($2.66B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TARS or REGN in 2026?
The choice between TARS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TARS and REGN?
TARS (Tarsus Pharmaceuticals Inc) has a market cap of $2.66B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.